Xbiotech Insider Bought Shares Worth $711,251, SEC Filing Shows
A recent SEC filing reports that 10% owner and director John Simard bought shares on October 26, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.